Journal
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 10, Issue 8, Pages 1217-1226Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1517/14712598.2010.500284
Keywords
chronic renal failure; mesenchymal stem cell; paracrine effect; regenerative medicine
Ask authors/readers for more resources
Importance of the field: Chronic kidney disease (CKD) has become a worldwide public health problem. Renal transplantation is the treatment of choice for end-stage renal disease, but is limited by a small number of organ donors and the immune barrier. To overcome these problems, new therapeutic strategies for tissue repair have recently emerged. Areas covered in this review: We discuss the therapeutic potential of mesenchymal stem cells (MSCs) in kidney injury and examine the latest reports providing evidence supporting MSC efficacy in the treatment of chronic renal failure (CRF). What the reader will gain: MSCs improve histological and functional outcomes in various CRF model systems. Paracrine effects rather than trans-differentiation might result in the prevention of progressive renal failure. In addition, MSCs can reprogram kidney cell differentiation, and modulate neo-kidney transplantation in CRF. Take home message: Although many practical problems remain to be addressed, treatment with MSCs will enter the mainstream of CRF treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available